Literature DB >> 29532351

Bioluminescence Imaging for Monitoring miR-200c Expression in Breast Cancer Cells and its Effects on Epithelial-Mesenchymal Transition Progress in Living Animals.

Jing Liu1, Jia-Xin Shen1,2, Guo-Jun Zhang3,4.   

Abstract

PURPOSE: Dysregulation of microRNAs (miRNAs) are not only involved in the formation of malignant tumors but also in the processes of differentiation and aggressiveness. However, current methods for detecting miRNA expression have major disadvantages, such as being invasive and non-reproducible. The epithelial-mesenchymal transition (EMT) has been implicated as a pivotal event in the metastasis, stemness, and chemoresistance of malignant tumors. PROCEDURES: In our study, we constructed a new reporter gene, Luc2/tdT_miR200c_3TS, to examine the in vitro and in vivo expression of miR-200c, an EMT-associated miRNA. Quantitative real-time PCR was used to measure the expression levels of miR-200c and EMT-related mRNA, and luciferase assay and bioluminescence imaging were used to measure the luciferase activities in vitro and in vivo, respectively.
RESULTS: We found that the expression level of miR-200c was negatively associated with cell migration and invasion. Luciferase activities were regulated by the differential expression levels of miR-200c and EMT process.
CONCLUSIONS: Our results demonstrate that Luc2/tdT_miR200c_3TS may be a useful tool for monitoring the expression level of miR-200c at both the cellular level and in living animals, thereby providing a potential high-throughput approach for anticancer drug screening.

Entities:  

Keywords:  Bioluminescence; Breast cancer; In vivo imaging; miR-200c

Mesh:

Substances:

Year:  2018        PMID: 29532351     DOI: 10.1007/s11307-018-1180-4

Source DB:  PubMed          Journal:  Mol Imaging Biol        ISSN: 1536-1632            Impact factor:   3.488


  25 in total

1.  APF lncRNA regulates autophagy and myocardial infarction by targeting miR-188-3p.

Authors:  Kun Wang; Cui-Yun Liu; Lu-Yu Zhou; Jian-Xun Wang; Man Wang; Bing Zhao; Wen-Ke Zhao; Shi-Jun Xu; Li-Hua Fan; Xiao-Jie Zhang; Chang Feng; Chao-Qun Wang; Yan-Fang Zhao; Pei-Feng Li
Journal:  Nat Commun       Date:  2015-04-10       Impact factor: 14.919

2.  Human umbilical cord mesenchymal stem cells ameliorate experimental cirrhosis through activation of keratinocyte growth factor by suppressing microRNA-199.

Authors:  Z-M Bi; Q-F Zhou; Y Geng; H-M Zhang
Journal:  Eur Rev Med Pharmacol Sci       Date:  2016-12       Impact factor: 3.507

3.  MicroRNA-200c attenuates tumour growth and metastasis of presumptive head and neck squamous cell carcinoma stem cells.

Authors:  Wen-Liang Lo; Cheng-Chia Yu; Guang-Yuh Chiou; Yi-Wei Chen; Pin-I Huang; Chian-Shiu Chien; Ling-Ming Tseng; Pen-Yuan Chu; Kai-Hsi Lu; Kuo-Wei Chang; Shou-Yen Kao; Shih-Hwa Chiou
Journal:  J Pathol       Date:  2011-01-05       Impact factor: 7.996

4.  MiR-520b/e Regulates Proliferation and Migration by Simultaneously Targeting EGFR in Gastric Cancer.

Authors:  Shuang Li; Haiyang Zhang; Tao Ning; Xinyi Wang; Rui Liu; Haiou Yang; Yueting Han; Ting Deng; Likun Zhou; Le Zhang; Ming Bai; Xia Wang; Shaohua Ge; Guoguang Ying; Yi Ba
Journal:  Cell Physiol Biochem       Date:  2016-12-19

Review 5.  EMT, CSCs, and drug resistance: the mechanistic link and clinical implications.

Authors:  Tsukasa Shibue; Robert A Weinberg
Journal:  Nat Rev Clin Oncol       Date:  2017-04-11       Impact factor: 66.675

Review 6.  Forcing through Tumor Metastasis: The Interplay between Tissue Rigidity and Epithelial-Mesenchymal Transition.

Authors:  Spencer C Wei; Jing Yang
Journal:  Trends Cell Biol       Date:  2015-10-24       Impact factor: 20.808

7.  Bioluminescence imaging of DNA synthetic phase of cell cycle in living animals.

Authors:  Zhi-Hong Chen; Rui-Jun Zhao; Rong-Hui Li; Cui-Ping Guo; Guo-Jun Zhang
Journal:  PLoS One       Date:  2013-01-03       Impact factor: 3.240

Review 8.  Advances in optical imaging for pharmacological studies.

Authors:  Alicia Arranz; Jorge Ripoll
Journal:  Front Pharmacol       Date:  2015-09-11       Impact factor: 5.810

9.  miR-151-3p Targets TWIST1 to Repress Migration of Human Breast Cancer Cells.

Authors:  Ting-Chih Yeh; Tzu-Ting Huang; Tien-Shun Yeh; Yu-Ren Chen; Kai-Wen Hsu; Pen-Hui Yin; Hsin-Chen Lee; Ling-Ming Tseng
Journal:  PLoS One       Date:  2016-12-08       Impact factor: 3.240

10.  MicroRNA-181 Variants Regulate T Cell Phenotype in the Context of Autoimmune Neuroinflammation.

Authors:  Samira Ghorbani; Farideh Talebi; Wing Fuk Chan; Farimah Masoumi; Mohammed Vojgani; Christopher Power; Farshid Noorbakhsh
Journal:  Front Immunol       Date:  2017-07-19       Impact factor: 7.561

View more
  5 in total

1.  Inflammatory Breast Carcinoma: Elevated microRNA miR-181b-5p and Reduced miR-200b-3p, miR-200c-3p, and miR-203a-3p Expression as Potential Biomarkers with Diagnostic Value.

Authors:  Sarah Atef Fahim; Mahmoud Salah Abdullah; Nancy A Espinoza-Sánchez; Hebatallah Hassan; Ayman M Ibrahim; Sarah Hamdy Ahmed; George Shakir; Mohamed A Badawy; Nadia I Zakhary; Burkhard Greve; Mohamed El-Shinawi; Martin Götte; Sherif Abdelaziz Ibrahim
Journal:  Biomolecules       Date:  2020-07-16

2.  Analysis of the Differentially Expressed Genes Induced by Cisplatin Resistance in Oral Squamous Cell Carcinomas and Their Interaction.

Authors:  Hua-Tao Wu; Wen-Tian Chen; Guan-Wu Li; Jia-Xin Shen; Qian-Qian Ye; Man-Li Zhang; Wen-Jia Chen; Jing Liu
Journal:  Front Genet       Date:  2020-01-23       Impact factor: 4.599

Review 3.  Preclinical Imaging Evaluation of miRNAs' Delivery and Effects in Breast Cancer Mouse Models: A Systematic Review.

Authors:  Francesca Maria Orlandella; Luigi Auletta; Adelaide Greco; Antonella Zannetti; Giuliana Salvatore
Journal:  Cancers (Basel)       Date:  2021-11-30       Impact factor: 6.639

Review 4.  Mesenchymal stem cell-derived exosomes as new tools for delivery of miRNAs in the treatment of cancer.

Authors:  Aysegul Dalmizrak; Ozlem Dalmizrak
Journal:  Front Bioeng Biotechnol       Date:  2022-09-26

Review 5.  MicroRNAs and Metastasis.

Authors:  Carla Solé; Charles H Lawrie
Journal:  Cancers (Basel)       Date:  2019-12-30       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.